Inexpensive rinsing effective at reducing post-op infection following joint replacement surgery

February 17, 2011, Rush University Medical Center

A rinsing technique with betadine that costs just a little over one dollar per patient may significantly reduce the infection rate following total knee and hip joint replacement surgery according to a study by researchers at Rush University Medical Center.

The study, presented at the American Association of Orthopedic Surgeons 2011 Annual Meeting, found that a three minute diluted betadine lavage combined with painting of the skin with a 10% betadine solution prior to surgical closure nearly eliminated early deep post-operative infection.

Deep periprosthetic joint infection is a rare but devastating complication associated with total . Despite aseptic techniques, careful skin preparation and , deep infections still occur with a prevalence ranging from 0.3% to 1.9%.

Previous research has shown that a diluted betadine lavage of the surgical wound prior to closure reduces the rate of post-operative infection in orthopedic, urologic, cardiovascular and general surgery but it has not been previously studied in total joint arthroplasty.

"Betadine is safe, inexpensive, simple to use, and readily available within most operating rooms," said study author Dr. Craig Della Valle, associate professor of at Rush. "In addition, betadine is effective on many types of bacteria including methicillin-resistant Staphylococcus Aureus (MRSA).

Researchers implemented a protocol for primary total knee and total hip arthroplasty in which the wound is soaked with the diluted betadine solution for three minutes following implantation of the prosthetic components. This is followed by a pulsating lavage of normal saline without antibiotics. Prior to final closure, betadine is applied to the skin surrounding the incision. Prior to this protocol, wounds were lavaged with normal saline only.

Acute post-operative deep infection was diagnosed in 18 out of the 1862 cases performed prior to the initiation of the betadine lavage protocol and in only one of the 688 total joint arthroplasties following initiation of this protocol; a reduction of the infection rate from 0.97% to 0.15%. There were no side complications associated with the treatment.

The study authors caution there are some limitations to the study. Changes in the surgeon's technique occurred over the time of the study, and it was not feasible to determine the impact of these changes on the rate of . These included variations in the incision size, suture material, and type of skin sealant.

Related Stories

Recommended for you

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

A new class of drug to treat herpes simplex virus-1 infection

February 14, 2018
For patients with the herpes simplex-1 virus (HSV-1), there are just a handful of drugs available to treat the painful condition that can affect the eyes, mouth and genitals.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.